Trainee Pearls podcast

#18 Jurjen Versluis: Transplant for high-risk MDS

29.10.2023
0:00
20:34
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Allogeneic hematopoietic cell transplantation (HCT) in patients with myelodysplastic syndrome (MDS) improves overall survival. The authors evaluated the impact of MDS genetics on the benefit of HCT in a biological assignment (donor v no donor) study. https://pubmed.ncbi.nlm.nih.gov/37607457/ ALSO AS VIDEO ON https://youtu.be/JbHS_-2sJQc CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/CarmeloGurnari


Flere episoder fra "Trainee Pearls"